4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-026941
CEO sold 5,483 shares at $18.18 ($99,691)
- CEO acquired 15,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2022-04-29 | Option exercise | +15,625 | 81,358 | D | ||
| DAVIS STEPHEN CEO | 2022-05-02 | Sale | −5,483 | $18.18 | $99,691 | 75,875 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2022-04-29 | Option exercise · Restricted Stock Units | −15,625 | 15,625 | D | ||
| Open-market sales · 5,483 sh · avg $18.18 · $99,691 | |||||||
Loading xslF345X03/doc4.xml…